Traditional Chinese medicine as potential adjuvants for tumor vaccines: a review of types, mechanisms, and forms
Authors:
Open Access
- 10 December 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1661694
Abstract
Therapeutic cancer vaccines are increasingly recognized as a highly promising approach for tumor treatment; however, their clinical efficacy critically depends on the rational design of vaccine adjuvants. Natural compounds derived from Traditional Chinese Medicine (TCM) have emerged as attractive candidates for next-generation tumor vaccine adjuvants. In this review, we systematically summarize the chemical constituents of TCM-derived adjuvants reported in current research and categorize their mechanisms of action into four functional modalities: (i) immunostimulatory adjuvants that activate innate immune pathways; (ii) delivery-enhancing systems that improve antigen stability and facilitate targeting to antigen-presenting cells; (iii) integrated platforms that combine both immunostimulatory and delivery-enhancing functions; and (iv) other mechanisms involving non-canonical immunomodulatory activities. We further discuss current challenges in standardization, regulatory approval, and clinical translation, offering a roadmap for harnessing the potential of TCM in the rational design of cancer vaccines.Keywords
This publication has 140 references indexed in Scilit:
- Screening Natural Cholesterol Analogs to Assemble Self‐Adjuvant Lipid Nanoparticles for Antigens Tagging Guided Therapeutic Tumor VaccineAdvanced Materials, 2025
- Natural Products from Herbal Medicine Self‐Assemble into Advanced Bioactive MaterialsAdvanced Science, 2024
- Exosome nanovesicles: biomarkers and new strategies for treatment of human diseasesMedcomm, 2024
- Immunogenicity of Extracellular VesiclesAdvanced Materials, 2024
- Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.Advanced Healthcare Materials, 2024
- Immunologic tumor microenvironment modulators for turning cold tumors hotCancer Communications, 2024
- Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and MetastasisAdvanced Science, 2024
- Inherent Capability of Self‐Assembling Nanostructures in Specific Proteasome Activation for Cancer Cell PyroptosisSmall, 2022
- Engineering the Deformability of Albumin‐Stabilized Emulsions for Lymph‐Node Vaccine DeliveryAdvanced Materials, 2021
- Particulate Alum via Pickering Emulsion for an Enhanced COVID‐19 Vaccine AdjuvantAdvanced Materials, 2020